tiprankstipranks
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
2269
Wuxi Biologics (Cayman)
RESEARCH TOOLSreports
Want to see HK:2269 full AI Analyst Report?

Wuxi Biologics (Cayman) (2269) Revenue

55 Followers
StatisticsMarket CapRevenue

Wuxi Biologics (Cayman) Revenue

Wuxi Biologics (Cayman) had a revenue of 11.64B in the quarter ending Dec 31, 2025, with 16.94%. This bring the company's revenue in the last twelve months to 21.59B, Decreased 7.67%. In the fiscal year ending Dec 31, 2025, Wuxi Biologics (Cayman) had annual revenue of 21.23B with 13.66% growth.
Revenue (ttm)
21.59B
Revenue Growth
16.79%
P/S Ratio
6.37
Revenue/Employee
HK$1,687,958
Employees
12,575
Market Cap
HK$135.24B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
21.23B2.55B+13.66%
Dec 31, 2024
18.68B1.64B+9.63%
Dec 31, 2023
17.03B1.77B+11.56%
Dec 31, 2022
15.27B4.98B+48.38%
Dec 31, 2021
10.29B4.68B+83.35%
Dec 31, 2020
5.61B1.63B+40.88%
Dec 31, 2019
3.98B1.45B+57.18%
Dec 31, 2018
2.53B915.62M+56.56%
Dec 31, 2017
1.62B――